Literature DB >> 23608864

Cervical tourniquet in case of uncontrollable haemorrhage during caesarean section owing to a placenta accreta.

Q C A Huijgen1, A F Gijsen, E Hink, P J M Van Kesteren.   

Abstract

This case report describes a 38-year-old woman in whom a primary caesarean section for placenta previa was complicated by postpartum haemorrhage due to a placenta accreta. Despite tamponade with a Bakri balloon and placement of a B-Lynch suture, the amount of blood loss could not be effectively reduced. The blood loss was eventually minimised by the placement of a Penrose drain around the cervix as a cervical tourniquet. We think that a cervical tourniquet is an effective method of stopping haemorrhage during caesarean section, as shown in this case report, and we consider this technique to be a valuable addition to several existing methods through which fertility is preserved by preventing emergency hysterectomy.

Entities:  

Mesh:

Year:  2013        PMID: 23608864      PMCID: PMC3645133          DOI: 10.1136/bcr-2013-009237

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage.

Authors:  Anke Diemert; Gerhard Ortmeyer; Bettina Hollwitz; Manuela Lotz; Thierry Somville; Peter Glosemeyer; Werner Diehl; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2011-07-30       Impact factor: 8.661

2.  Reducing blood loss at open myomectomy using triple tourniquets: a randomised controlled trial.

Authors:  A Taylor; M Sharma; P Tsirkas; A Di Spiezio Sardo; M Setchell; A Magos
Journal:  BJOG       Date:  2005-03       Impact factor: 6.531

3.  Emergency obstetric hysterectomy.

Authors:  George Daskalakis; Eleftherios Anastasakis; Nikolaos Papantoniou; Spyros Mesogitis; Mariana Theodora; Aris Antsaklis
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

4.  Methotrexate treatment for retained placental tissue.

Authors:  F Flam; P O Karlström; B Carlsson; L Garoff
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-04       Impact factor: 2.435

5.  Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus.

Authors:  S A AbdRabbo
Journal:  Am J Obstet Gynecol       Date:  1994-09       Impact factor: 8.661

6.  Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta?

Authors:  J M Beuker; J J H M Erwich; T Y Khong
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

7.  Placenta accreta following uterine artery embolization.

Authors:  Hironori Takahashi; Satoshi Hayashi; Kentaro Matsuoka; Michihiro Kitagawa
Journal:  Taiwan J Obstet Gynecol       Date:  2010-06       Impact factor: 1.705

8.  Clinical risk factors for placenta previa-placenta accreta.

Authors:  D A Miller; J A Chollet; T M Goodwin
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

9.  Utility of the pulsatility index of the uterine arteries and human chorionic gonadotropin in a series of cases of placenta accreta.

Authors:  Omar Felipe Dueñas-Garcia; Maricela Diaz-Sotomayor; Hugo Rico-Olvera
Journal:  J Obstet Gynaecol Res       Date:  2011-04-04       Impact factor: 1.730

10.  The use of torniquet to reduce blood loss at myomectomy.

Authors:  J I Ikechebelu; C O Ezeama; N J A Obiechina
Journal:  Niger J Clin Pract       Date:  2010-06       Impact factor: 0.968

  10 in total
  1 in total

1.  FIGO recommendations on the management of postpartum hemorrhage 2022.

Authors:  Maria Fernanda Escobar; Anwar H Nassar; Gerhard Theron; Eythan R Barnea; Wanda Nicholson; Diana Ramasauskaite; Isabel Lloyd; Edwin Chandraharan; Suellen Miller; Thomas Burke; Gabriel Ossanan; Javier Andres Carvajal; Isabella Ramos; Maria Antonia Hincapie; Sara Loaiza; Daniela Nasner
Journal:  Int J Gynaecol Obstet       Date:  2022-03       Impact factor: 4.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.